Brief: Aker Biomarine launches new business segment

Aker Biomarine ASA

24/11/2020 07:18

Nov 24 (Reuters) - Aker Biomarine AS  AKBM-ME.OL :
    * AKER BIOMARINE LAUNCHES NEW BUSINESS SEGMENT WITH BROAD
APPLICATION POTENTIAL
    * IS TODAY LAUNCHING LYSOVETATM, A NEW DELIVERY PLATFORM
BASED ON
LPC-BOUND EPA AND DHA FROM KRILL
    * THIS IS A SIGNIFICANT BREAKTHROUGH THAT WILL OPEN UP NEW
OPPORTUNITIES AND NEW LARGE MARKETS WITHIN BRAIN, EYE AND OTHER
IMPORTANT HEALTH AREAS
    * SCALING UP PRODUCTION CAPACITY OF MOLECULE AT ITS
MANUFACTURING
PLANT IN HOUSTON, AND EXPECTS REGULATORY APPROVAL FOR DIETARY
SUPPLEMENT VERSION OF LYSOVETATM BY END OF 2022
    * NOW ACTIVELY SEEKING PARTNERS TO PURSUE COMMERCIAL
OPPORTUNITIES
IN PHARMACEUTICAL AND INFANT FORMULA SEGMENT

Source text for Eikon:  urn:newsml:reuters.com:*:nObiJQFX1a
Further company coverage:  AKBM-ME.OL 

 (Reporting by Oslo newsroom)
 ((terje.solsvik@thomsonreuters.com;))